FIELD: pharmacy, cosmetics. SUBSTANCE: invention relates to associates of the deprotonized hyaluronic acid with zinc or cobalt ions. Method of their preparing involves interaction of zinc or cobalt halogenide an aqueous solution at equimole ratio of reagents followed by precipitation of an associate using alkanol or alkanone and separation of precipitate from solution. Pharmaceutical composition has an effective amount of associate of the deprotonized hyaluronic acid, pharmaceutically acceptable carrier and special additions. Pharmaceutical composition is prepared by its components mixing. EFFECT: improved method of preparing. 7 cl, 3 dwg , 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BIOLOGICALLY ACTIVE COMPOSITION PREPARING | 1991 |
|
RU2021304C1 |
| AGENT FOR TREATMENT OF FUNGAL INFECTION, GASTRIC AND DUODENAL ULCERS INDUCED BY HELICOBACTER PYLORI | 1997 |
|
RU2204394C2 |
| METHOD FOR PREPARING WATER-SOLUBLE SALINE COMPLEXES OF HYALURONIC ACID (VARIANTS) | 2005 |
|
RU2280041C1 |
| PEPTIDE DERIVATIVES OR ACID ADDITION SALTS THEREOF AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2037499C1 |
| HYDROGEL WATER-SOLUBLE COMPOSITION BASED ON HYALURONIC ACID AND POLYVALENT METAL IONS AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2710074C1 |
| PENTAPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINS INHIBITOR OF PROLIFERATION OF EPIDERMAL CELLS | 1991 |
|
RU2018510C1 |
| METHOD FOR OBTAINING MODIFIED HYALURONIC ACID AND ITS SALTS | 2021 |
|
RU2804641C2 |
| CROSS-LINKED HYALURONIC ACIDS AND THEIR APPLICATION IN MEDICINE | 1999 |
|
RU2230752C2 |
| FRACTION OF HYALURONIC ACID OR ITS SALT, METHOD OF PURIFICATION OF THIS FRACTION, METHODS OF PREPARING THIS FRACTION, PHARMACEUTICAL PREPARATION AND AGENTS USED IN OPHTHALMOLOGY | 1992 |
|
RU2128666C1 |
| DERIVATIVE OF HYALURONIC ACID AND MEDICAL AGENT THAT CONTAINS IT | 2005 |
|
RU2390529C2 |
